Skip to content
IP + Technology Law
Home  »  News & Insights  »  News

Partner Josh Stowell was quoted in, “In Post-Alice Patent World, Diagnostics Turn To Trade Secrets Protection,” an article published by Medtech Insight.

October 11, 2018  | Joshua Stowell

Partner Joshua Stowell was quoted in, “In Post-Alice Patent World, Diagnostics Turn To Trade Secrets Protection,” an article published by Medtech Insight.

Excerpt: Recent legal cases have made some diagnostics unpatentable because they rely on detecting natural phenomenon. An attorney involved in patent law offered Medtech Insight some insight on how developers can use trade secrets to protect their ideas.

Read full article here >> (Subscription Required)

Partner Josh Stowell was quoted in, “In Post-Alice Patent World, Diagnostics Turn To Trade Secrets Protection,” an article published by Medtech Insight. Headshot

Joshua Stowell

For over a decade, Joshua has successfully represented and counseled clients in technology and intellectual property disputes. He has litigated cases relating to patents, trademarks, copyrights, trade secrets, unfair competition,...

Related Links

Practice Areas

News & Insights

News
Oct 2024
Joshua Stowell Quoted in Managing IP on Helping Clients Navigate Multi-Patent Lawsuits
In the Managing IP article “How Multi-Patent Suits Shape Law Firm Advice,” partner Joshua Stowell discussed the ways he helps clients manage the complexities of multi-patent lawsuits. Stowell, co-chair of...
Blog - PTAB
Jan 2024
Current Congressional Attempts at Patent Reform
In recent years, Congress has considered potential new laws for patent reform, typically changes to the system supported by patent owners. Two main areas of focus are “Section 101” and the “PTAB.” Below is a summary of two such efforts currently being considered by Congress.
Blog - Litigation
Aug 2023
A Terminal Disclaimer Is Not an Escape Hatch
IN RE CELLECT, LLC Before Lourie, Dyk, and Reyna. Appeal from the Patent Trial and Appeal Board. Summary: Obviousness-type double patenting analyses for patents with Patent Term Adjustments are based on the adjusted expiration date of the patent.